Unveiling Beauty Health (SKIN) Q4 Outlook: Wall Street Estimates for Key Metrics

Core Viewpoint - Analysts expect The Beauty Health Company (SKIN) to report a quarterly loss of -$0.07 per share, reflecting a year-over-year increase of 12.5%, with revenues projected at $78.17 million, down 6.4% from the previous year [1] Financial Projections - The consensus EPS estimate for the upcoming quarter has remained unchanged over the past 30 days, indicating a reassessment of initial projections by covering analysts [1] - Analysts predict 'Delivery Systems Net Sales' to be $20.85 million, representing a year-over-year decline of 22.2% [4] - The average estimate for 'Consumables Net Sales' is $57.34 million, indicating a slight year-over-year increase of 1.1% [4] - 'Geographic Revenue- Americas' is expected to reach $53.65 million, reflecting a decrease of 6% from the year-ago quarter [4] - 'Geographic Revenue- EMEA' is projected at $17.20 million, while 'Geographic Revenue- Asia Pacific (APAC)' is expected to be $7.49 million, showing a year-over-year decline of 18.6% [5] Market Performance - Shares of Beauty Health have decreased by 10.9% over the past month, contrasting with a 2.7% decline in the Zacks S&P 500 composite [5] - The company holds a Zacks Rank 4 (Sell), suggesting it is expected to underperform the overall market in the near future [5]